GCT President at 17th Annual MCI Symposium

GCT President, Dr. Jeffrey T. Apter will attend the 17th Annual MCI (Mild Cognitive Impairment) Symposium. The event will take place in Miami, FL on January 19-20.

These are some topics that will be discussed during the event:

  • Vascular and AD pathology interaction in MCI and dementia
  • MRI and PET scans in the diagnosis
  • Evidence for the effectiveness of neuromodulation
  • Cognitive training and behavioral intervention in maintaining cognition and everyday function.

GCT has a vast expertise in the CNS area, effectively managing numerous trials in Alzheimer’s disease, Multiple Sclerosis, Epilepsy and other medical conditions. We are always looking for new opportunities to learn more and to share our experience.

Subscribe to our mailing list

Marketing Permissions

Please select all the ways you would like to hear from Global Clinical Trials (GCT):

You can unsubscribe at any time by clicking the link in the footer of our emails. Please see our Privacy Policy. We use Mailchimp as our marketing platform. By clicking below to subscribe, you acknowledge that your information will be transferred to Mailchimp for processing. Learn more about Mailchimp's privacy practices here.

About

GCT is a CRO experienced in performing clinical research in the USA, Europe, Russia and India.

We are a full-service clinical development provider, offering feasibility analysis, regulatory submission, site selection, project management, monitoring, data management, logistics, and more.

Go social with us

Follow us on social networks:

Privacy policy, Terms of service, Site map, Employees login

 

GCT

© 2001—2019 Global Clinical Trials, LLC

All rights reserved.